{"id":148046,"date":"2022-10-12T19:22:24","date_gmt":"2022-10-13T00:22:24","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/10\/genflow-bio-scoops-e250k-to-accelerate-antiaging-gene-therapy-platform"},"modified":"2022-10-12T19:22:24","modified_gmt":"2022-10-13T00:22:24","slug":"genflow-bio-scoops-e250k-to-accelerate-antiaging-gene-therapy-platform","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/10\/genflow-bio-scoops-e250k-to-accelerate-antiaging-gene-therapy-platform","title":{"rendered":"Genflow Bio scoops \u20ac250k to accelerate antiaging gene therapy platform"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/genflow-bio-scoops-e250k-to-accelerate-antiaging-gene-therapy-platform2.jpg\"><\/a><\/p>\n<p>Genflow has announced that its adeno-associated virus (AAV) research and development programme in Estonia has received a non-dilutive grant award of \u20ac250,000 from the Applied Research Programme of Enterprise Estonia, an Estonian governmental institution designed to stimulate business growth in the country.<\/p>\n<p><strong><em>Longevity. Technology: Genflow\u2019s research programme is focused on the development of an antiaging gene therapy platform designed to target nearly 100 million patients worldwide who suffer from Werner\u2019s syndrome, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis, an advanced form of NAFLD, as well as other major clinical disorders.<\/em><\/strong><\/p>\n<p><strong><em>This R&amp;D is a collaborative project between Genflow and IVEX lab O\u00dc, an Estonian company specialising in the research and development of biotech therapeutics.<\/em><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genflow has announced that its adeno-associated virus (AAV) research and development programme in Estonia has received a non-dilutive grant award of \u20ac250,000 from the Applied Research Programme of Enterprise Estonia, an Estonian governmental institution designed to stimulate business growth in the country. Longevity. Technology: Genflow\u2019s research programme is focused on the development of an antiaging [\u2026]<\/p>\n","protected":false},"author":664,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,269],"tags":[],"class_list":["post-148046","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/148046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/664"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=148046"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/148046\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=148046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=148046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=148046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}